1.Promotion of HBeAg seroconversion/loss in patients with chronic hepatitis B following the switch from nucleoside drugs to telbivudine and adefovir.
Sunan CUI ; Mingming WANG ; Yanxue GONG
Chinese Journal of Hepatology 2014;22(10):776-778
Adenine
;
analogs & derivatives
;
therapeutic use
;
Drug Combinations
;
Hepatitis B e Antigens
;
blood
;
Hepatitis B, Chronic
;
drug therapy
;
Humans
;
Nucleic Acid Synthesis Inhibitors
;
therapeutic use
;
Nucleosides
;
antagonists & inhibitors
;
biosynthesis
;
Organophosphonates
;
therapeutic use
;
Thymidine
;
analogs & derivatives
;
therapeutic use